LINC02417

Across TCGA pan-cancer cohorts, LINC02417 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated LINC02417 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher LINC02417 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated LINC02417 expression acts as an unfavorable survival marker, although some lineages such as CESC and HNSC show a favorable association.

SKCM, CESC, and UCEC are the cancer types where LINC02417 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	All	0.094	0.214	.001	36	view →
CESC	OS	Median	IV	0.815	0.426	.041	24	view →
UCEC	OS	Quartile	IV	0.513	0.872	.021	20	view →
THYM	DFS	Tertile	III,IV	0.214	1.000	.008	19	view →
COAD	OS	Tertile	IV	0.183	0.670	.003	18	view →
LGG	OS	Tertile	All	0.758	0.908	<.001	18	view →
LUSC	OS	Tertile	III,IV	0.177	0.438	.006	17	view →
GBM	OS	Quartile	All	0.200	0.293	.011	12	view →
LUAD	OS	Median	IV	0.315	0.699	.028	12	view →
PAAD	DFS	Tertile	III,IV	0.152	0.821	.045	9	view →
READ	DFS	Tertile	All	0.231	0.624	.007	9	view →
HNSC	OS	Quartile	IV	0.528	0.314	.020	7	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

LINC02417–SKCM (DFS)

Open the SKCM breakdown →